Without policy intervention to address average sales price-based challenges to biosimilar market sustainability, there is a ...
The Centers for Medicare & Medicaid Services (CMS) recently issued several important updates concerning the reporting of Average Sales Price (ASP) with potential implications for manufacturers. These ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback